- Home
- CGEN vs GLDG Comparison
CGEN vs GLDG Comparison
Compare CGEN & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- GLDG
- Stock Information
- Founded
- CGEN 1993
- GLDG 2009
- Country
- CGEN Israel
- GLDG Canada
- Employees
- CGEN N/A
- GLDG N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- GLDG Precious Metals
- Sector
- CGEN Health Care
- GLDG Basic Materials
- Exchange
- CGEN Nasdaq
- GLDG Nasdaq
- Market Cap
- CGEN 135.6M
- GLDG 157.0M
- IPO Year
- CGEN 2000
- GLDG N/A
- Fundamental
- Price
- CGEN $1.47
- GLDG $0.83
- Analyst Decision
- CGEN Strong Buy
- GLDG Strong Buy
- Analyst Count
- CGEN 1
- GLDG 1
- Target Price
- CGEN $4.00
- GLDG $3.25
- AVG Volume (30 Days)
- CGEN 268.4K
- GLDG 597.1K
- Earning Date
- CGEN 05-19-2025
- GLDG 04-29-2025
- Dividend Yield
- CGEN N/A
- GLDG N/A
- EPS Growth
- CGEN N/A
- GLDG N/A
- EPS
- CGEN N/A
- GLDG N/A
- Revenue
- CGEN $27,864,000.00
- GLDG N/A
- Revenue This Year
- CGEN $11.81
- GLDG N/A
- Revenue Next Year
- CGEN $28.37
- GLDG N/A
- P/E Ratio
- CGEN N/A
- GLDG N/A
- Revenue Growth
- CGEN N/A
- GLDG N/A
- 52 Week Low
- CGEN $1.13
- GLDG $0.71
- 52 Week High
- CGEN $2.66
- GLDG $1.06
- Technical
- Relative Strength Index (RSI)
- CGEN 49.50
- GLDG 52.62
- Support Level
- CGEN $1.13
- GLDG $0.81
- Resistance Level
- CGEN $1.35
- GLDG $0.77
- Average True Range (ATR)
- CGEN 0.11
- GLDG 0.04
- MACD
- CGEN 0.03
- GLDG 0.01
- Stochastic Oscillator
- CGEN 85.00
- GLDG 75.00
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia, Crucero project, located in Peru, Sao Jorge, Batistao, Boa Vista, located in Brazil, Yellowknife Gold Project, located in the Northwest Territories, Canada, and other projects. The company earns maximum revenue from Canada.